JP2020534284A5 - - Google Patents

Download PDF

Info

Publication number
JP2020534284A5
JP2020534284A5 JP2020515680A JP2020515680A JP2020534284A5 JP 2020534284 A5 JP2020534284 A5 JP 2020534284A5 JP 2020515680 A JP2020515680 A JP 2020515680A JP 2020515680 A JP2020515680 A JP 2020515680A JP 2020534284 A5 JP2020534284 A5 JP 2020534284A5
Authority
JP
Japan
Prior art keywords
protein
composition according
rsv
composition
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020515680A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020534284A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/051054 external-priority patent/WO2019055768A1/en
Publication of JP2020534284A publication Critical patent/JP2020534284A/ja
Publication of JP2020534284A5 publication Critical patent/JP2020534284A5/ja
Pending legal-status Critical Current

Links

JP2020515680A 2017-09-15 2018-09-14 ワクチン、並びに、呼吸器合胞体ウイルス（ｒｓｖ）感染症を予防するためのワクチンの作製方法及び使用方法 Pending JP2020534284A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762559167P 2017-09-15 2017-09-15
US62/559,167 2017-09-15
PCT/US2018/051054 WO2019055768A1 (en) 2017-09-15 2018-09-14 VACCINES AND METHODS OF MAKING AND USING VACCINES FOR THE PREVENTION OF SYNCYTIAL RESPIRATORY VIRUS (RSV) INFECTIONS

Publications (2)

Publication Number Publication Date
JP2020534284A JP2020534284A (ja) 2020-11-26
JP2020534284A5 true JP2020534284A5 (enExample) 2021-10-21

Family

ID=65723867

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020515680A Pending JP2020534284A (ja) 2017-09-15 2018-09-14 ワクチン、並びに、呼吸器合胞体ウイルス（ｒｓｖ）感染症を予防するためのワクチンの作製方法及び使用方法

Country Status (8)

Country Link
US (1) US20200276297A1 (enExample)
EP (1) EP3681523A4 (enExample)
JP (1) JP2020534284A (enExample)
KR (1) KR20200096904A (enExample)
CN (1) CN111344008A (enExample)
AU (1) AU2018331467A1 (enExample)
CA (1) CA3075990A1 (enExample)
WO (1) WO2019055768A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7657727B2 (ja) 2019-04-02 2025-04-07 サノフイ 抗原性多量体呼吸器合胞体ウイルスポリペプチド
CN112226450B (zh) * 2020-08-25 2022-10-14 北京交通大学 一种共表达呼吸道合胞病毒融合前蛋白和黏附糖蛋白的复制缺陷型腺病毒载体疫苗
WO2023055154A1 (ko) * 2021-09-29 2023-04-06 에스케이바이오사이언스 주식회사 재조합된 약독화 rsv 생백신 및 이를 제조하는 방법
KR102806300B1 (ko) * 2023-01-13 2025-05-14 클립스비엔씨 주식회사 호흡기 신시치아 바이러스 변이체를 포함하는 호흡기 신시치아 바이러스 백신용 융합단백질 및 이의 제조방법
CN118930654A (zh) * 2023-05-12 2024-11-12 中国科学院微生物研究所 一种呼吸道合胞病毒抗原制备方法和应用
CN117720628A (zh) * 2023-10-12 2024-03-19 中国科学院微生物研究所 一种呼吸道合胞病毒二价抗原制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1224462A (zh) * 1996-07-15 1999-07-28 美国政府健康及人类服务部 从克隆的核苷酸序列制备减毒呼吸道合胞病毒疫苗的方法
BR0011159A (pt) * 1999-04-13 2002-07-23 Government Of The Us Dept Of H Método para produzir vacinas de vìrus rna de fita negativa atenuado a partir de sequências de nucleotìdeos clonados
WO2001092548A2 (en) * 2000-06-01 2001-12-06 St. Jude Children's Research Hospital Vaccine and gene therapy vector and methods of use thereof
AU2002327755A1 (en) * 2001-09-28 2003-04-14 Rush-Presbyterian-St. Luke's Medical Center Paramyxoviruses as gene transfer vectors to lung cells
CA2743750A1 (en) * 2002-02-21 2003-09-04 Medimmune, Llc Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from respiratory syncytial virus
DE60330966D1 (de) * 2002-07-26 2010-03-04 Canada Natural Resources Rekombinante vesicular stomatitis viren als impstoff gegen virale hämorrhagische fieber
KR101020532B1 (ko) * 2003-06-09 2011-03-09 와이어쓰 엘엘씨 ｃＤＮＡ로부터의 비분절 네가티브 쇄 ＲＮＡ 바이러스의 회수를 위한 개선된 방법
WO2005005645A1 (en) * 2003-06-13 2005-01-20 Apath, Llc Negative strand rna virus replicon
WO2005098009A2 (en) * 2004-04-09 2005-10-20 Wyeth Synergistic attenutation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof
US8772256B2 (en) * 2006-11-30 2014-07-08 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Codon modified immunogenic compositions and methods of use
US20090092635A1 (en) * 2007-08-17 2009-04-09 Wyeth Heterologous prime-boost immunization regimen
US20090162321A1 (en) * 2007-12-20 2009-06-25 Wyeth Methods for packaging propagation-defective vesicular stomatitis virus vectors using a stable cell line that expresses g protein
PE20110394A1 (es) * 2008-11-05 2011-06-22 Merck Sharp & Dohme Virus sincitial respiratorio vivo atenuado
KR102416194B1 (ko) * 2014-03-01 2022-07-04 프로펙츄스 바이오사이언스, 인크. 재조합 이스파한 바이러스 벡터
CA2951430A1 (en) * 2014-06-13 2015-12-17 Glaxosmithkline Biologicals Sa Immunogenic combinations

Similar Documents

Publication Publication Date Title
JP2020534284A5 (enExample)
JP2020022459A5 (enExample)
JP2019530462A5 (enExample)
PH12018501912A1 (en) Vaccine against rsv
JP2017048194A5 (enExample)
CN106659777A8 (zh) 免疫原性组合产品
JP2018520997A5 (enExample)
JP2017035093A5 (enExample)
JP2013507907A5 (enExample)
JP2016146837A5 (enExample)
ATE419369T1 (de) Chimäre mensch-rinder respiratory syncytial virus vakzinen
JP2016506416A5 (enExample)
JP2014502156A5 (enExample)
JP2015533841A5 (enExample)
JP2014503206A5 (enExample)
JP2016052331A5 (enExample)
JP2008500399A5 (enExample)
JP2014507146A5 (enExample)
JP2016533332A5 (enExample)
JP2015524422A5 (enExample)
JP2015501840A5 (enExample)
JP2010535026A5 (enExample)
JP2015509707A5 (enExample)
EA202090738A1 (ru) Способ безопасного индуцирования иммунитета против rsv
JP2010508030A5 (enExample)